AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine.

What it does

The legislature's own summary of the bill, or its official long title.

Opioids - As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.

Every action

5 steps, oldest first, as the legislature records them.

1. Jan 30, 2023SenateFiled for introduction
2. Feb 2, 2023SenateIntroduced, Passed on First Consideration
3. Feb 6, 2023CommitteePassed on Second Consideration, refer to Senate Health and Welfare Committee · Senate Health and Welfare Committee
4. Mar 8, 2023CommitteePlaced on Senate Health and Welfare Committee calendar for 3/15/2023 · Senate Health and Welfare Committee
5. Mar 15, 2023SenateAction deferred in Senate Health and Welfare Committee to 1/24/2024

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

• RC Rusty CroweR Primary sponsor · District 3